U.S. regulators delayed a decision on a proposed new anticlotting drug from Bristol-Myers Squib and Pfizer by three months to June 28, after the companies provided new information to the agency.
WSJ.com: What's News US, Wall Street Journal
Thu, 03/01/2012 - 10:43am
U.S. regulators delayed a decision on a proposed new anticlotting drug from Bristol-Myers Squib and Pfizer by three months to June 28, after the companies provided new information to the agency.